STAT+: Pharmalittle: Genentech finds no evidence of fraud in paper by former top exec; FDA withdraws approval for premature-birth drug
Genentech said a review of allegations concerning a paper co-authored by Marc Tessier-Lavigne did not find evidence of fraud or intentional wrongdoing.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal, and . And what about you? Given the spate of tumultuous news these past few days, perhaps spending time by calming ocean waters or in the solitude of a woodsy area is in order. Or you could zone out and binge-watch something fanciful on the telly. Or perhaps this is an opportunity to plan the rest of your life. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …
